nifedipine has been researched along with melatonin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.79) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| de Los Ríos, C; Egea, J; Gálvez, E; García, AG; Iriepa, I; León, R; López, MG; Marco-Contelles, J; Moraleda, I; Romero, A; Samadi, A; Villarroya, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Briones, AM; Egea, J; León, R; López, MG; Martínez-Revelles, S; Menéndez, JC; Parada, E; Ramos, MT; Sridharan, V; Tenti, G | 1 |
| Cano-Abad, MF; de los Ríos, C; González-Lafuente, L; Lajarín-Cuesta, R; Martínez-Sanz, FJ; Moreno-Ortega, AJ; Punzón, E | 1 |
| Araujo de Brito, M; Arranz-Tagarro, JA; Arribas, RL; de Los Ríos, C; Gandía, L; González-Lafuente, L; Lajarín-Cuesta, R; Nanclares, C | 1 |
| Arribas, RL; de Los Ríos, C; Gandía, L; García-Frutos, EM; Lajarín-Cuesta, R; Nanclares, C | 1 |
| Arribas, RL; Chabchoub, F; de Los Ríos, C; Demougeot, C; Diez-Iriepa, D; Egea, J; Godyń, J; Głuch-Lutwin, M; Iriepa, I; Ismaili, L; Kiec-Kononowicz, K; Kobrlova, T; Malawska, B; Malek, R; Marco-Contelles, J; Moraleda, I; Mordyl, B; Palomino-Antolin, A; Panek, D; Siwek, A; Soukup, O; Totoson, P | 1 |
| Oe, H; Satake, N; Shibata, S | 1 |
| Besharse, JC; Iuvone, PM | 1 |
| Satake, N; Shibata, S; Takagi, T; Usui, H | 1 |
| Buzzell, GR; Morton, DJ; Reiter, RJ | 1 |
| Joubert, WS; Kociszewska, VJ; Meyer, AC; Meyer, BJ; Nieuwenhuis, JJ | 1 |
| Bégay, V; Bois, P; Collin, JP; Falcón, J; Lenfant, J | 1 |
| Vanecek, J | 1 |
| Klein, DC; Vanecek, J | 1 |
| Koizumi, S; Moriyama, Y; Ogura, A; Yamada, H; Yamaguchi, A | 1 |
| Flanders, S; Lew, MJ | 1 |
| Vanecek, J; Zemková, H | 1 |
| Fogari, R; Lusardi, P; Piazza, E | 1 |
| Hill, M; Kanchev, L; Kancheva, R; Zofková, I | 1 |
| Lee, PP; Mei, YA; Pang, SF; Wei, H; Zhang, ZH | 1 |
| Monnet, FP | 1 |
| Barakat, M; El-Abhar, HS; El-Denshary, ES; Shaalan, M | 1 |
| Afeche, SC; Barbosa, R; Cipolla-Neto, J; Scialfa, JH; Simonneaux, V; Terra, IM | 1 |
| Ghibelli, L; Mengoni, F; Nuccitelli, S; Radogna, F | 1 |
2 trial(s) available for nifedipine and melatonin
| Article | Year |
|---|---|
Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Hypertension; Male; Melatonin; Middle Aged; Nifedipine | 2000 |
Lack of melatonin response to acute administration of nifedipine and diltiazem in healthy men.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Darkness; Diltiazem; Humans; Hydrocortisone; Male; Melatonin; Nifedipine; Prolactin; Time Factors | 2000 |
27 other study(ies) available for nifedipine and melatonin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Calcium; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytotoxins; Electron Transport Chain Complex Proteins; Electrophorus; Glucose; Hippocampus; Humans; Isomerism; Models, Molecular; Naphthyridines; Neuroprotective Agents; Okadaic Acid; Oligomycins; Oxygen; Peptide Fragments; Protein Binding; Protein Phosphatase 2; Rats; Rotenone; Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury.
Topics: Animals; Brain Ischemia; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cell Line, Tumor; Dihydropyridines; Hippocampus; Humans; Models, Molecular; Molecular Docking Simulation; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Inbred WKY; Reperfusion Injury | 2014 |
Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger.
Topics: Animals; Calcium; Cattle; Cell Line; Cell Line, Tumor; HeLa Cells; Hippocampus; Humans; Mitochondria; Neuroprotective Agents; Pyridines; Rats; Sodium-Calcium Exchanger; Solubility; Thiazepines | 2016 |
Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.
Topics: Alkaloids; Animals; Calcium Channels; Cattle; Cell Survival; Dose-Response Relationship, Drug; Hippocampus; Humans; Indole Alkaloids; Molecular Structure; Neurodegenerative Diseases; Phosphoprotein Phosphatases; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Design and synthesis of multipotent 3-aminomethylindoles and 7-azaindoles with enhanced protein phosphatase 2A-activating profile and neuroprotection.
Topics: Aza Compounds; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Indoles; Molecular Structure; Neuroprotective Agents; Protein Phosphatase 2; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H
Topics: Alzheimer Disease; Animals; Calcium Channel Blockers; Cholinesterase Inhibitors; Humans; Memory Disorders; Mice; Neuroblastoma; Neuroprotective Agents; Receptors, Histamine H3; Small Molecule Libraries; Tumor Cells, Cultured; Vasodilator Agents | 2019 |
Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta; Endothelium, Vascular; In Vitro Techniques; Male; Melatonin; Methylene Blue; Methysergide; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Nitroglycerin; Purinones; Rats; Rats, Inbred Strains; Verapamil | 1991 |
Involvement of calcium in the regulation of serotonin N-acetyltransferase in retina.
Topics: Acetyltransferases; Animals; Arylamine N-Acetyltransferase; Calcium; Chickens; Circadian Rhythm; Cobalt; Darkness; Gallopamil; Ion Channels; Magnesium; Melatonin; Nifedipine; Pineal Gland; Rats; Retina; Trifluoperazine; Xenopus laevis | 1986 |
Vasorelaxing action of melatonin in rabbit basilar artery.
Topics: Animals; Basilar Artery; In Vitro Techniques; Male; Melatonin; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Potassium Chloride; Rabbits; Serotonin | 1989 |
Swimming-induced suppression of rat pineal melatonin is prevented by pretreatment with calcium channel blockers.
Topics: Acetyltransferases; Animals; Arylamine N-Acetyltransferase; Male; Melatonin; Nifedipine; Physical Exertion; Pineal Gland; Rats; Rats, Inbred Strains; Reference Values; Swimming; Verapamil | 1989 |
Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons.
Topics: Animals; Calcium Channel Blockers; Male; Melatonin; Nifedipine; Nisoldipine; Nitrendipine; Papio; Verapamil | 1986 |
Calcium and melatonin production in dissociated trout pineal photoreceptor cells in culture.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcitonin; Calcium; Calcium Channels; Cells, Cultured; Dose-Response Relationship, Drug; Female; Melatonin; Nifedipine; Photoreceptor Cells; Pineal Gland; Time Factors; Trout; Verapamil | 1994 |
Cellular mechanism of melatonin action in neonatal rat pituitary.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Animals, Newborn; Drug Synergism; Enzyme Activation; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Melatonin; Nifedipine; Pituitary Gland; Protein Kinase C; Rats; Rats, Wistar; Second Messenger Systems; Tetradecanoylphorbol Acetate | 1995 |
Mechanism of melatonin signal transduction in the neonatal rat pituitary.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Animals, Newborn; Calcimycin; Calcium; Colforsin; Cyclic AMP; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Melatonin; Nifedipine; Organ Culture Techniques; Pituitary Gland, Anterior; Rats; Receptors, Cell Surface; Receptors, Melatonin; Signal Transduction | 1995 |
Acetylcholine triggers L-glutamate exocytosis via nicotinic receptors and inhibits melatonin synthesis in rat pinealocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Arylamine N-Acetyltransferase; Atropine; Bungarotoxins; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Carbachol; Cells, Cultured; Diltiazem; Exocytosis; Glutamic Acid; Melatonin; Muscarine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nifedipine; Nitrendipine; Oxotremorine; Parasympathetic Nervous System; Pineal Gland; Rats; Rats, Wistar; Receptors, Nicotinic; Scopolamine; Synaptic Vesicles; Tubocurarine | 1998 |
Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction.
Topics: Acetamides; Animals; Anticonvulsants; Arteries; Calcium Channel Blockers; Charybdotoxin; Colforsin; Dose-Response Relationship, Drug; Hypnotics and Sedatives; In Vitro Techniques; Indoles; Male; Melatonin; Nifedipine; Nitroprusside; Potassium Channels; Rats; Rats, Sprague-Dawley; Tail; Tryptamines; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1999 |
Differences in gonadotropin-releasing hormone-induced calcium signaling between melatonin-sensitive and melatonin-insensitive neonatal rat gonadotrophs.
Topics: Animals; Animals, Newborn; Antioxidants; Apamin; Calcium; Calcium Channel Blockers; Calcium Signaling; Electrophysiology; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Melatonin; Membrane Potentials; Nifedipine; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pituitary Gland; Potassium Channels; Rats; Ryanodine; Staurosporine; Type C Phospholipases | 2000 |
Melatonin and its analogs potentiate the nifedipine-sensitive high-voltage-activated calcium current in the chick embryonic heart cells.
Topics: Animals; Antioxidants; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chick Embryo; Drug Synergism; Melatonin; Membrane Potentials; Myocardium; Nifedipine; Patch-Clamp Techniques; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin | 2001 |
Melatonin modulates [3h]serotonin release in the rat hippocampus: effects of circadian rhythm.
Topics: Animals; Calcium Channel Blockers; Circadian Rhythm; Hippocampus; In Vitro Techniques; Male; Melatonin; Nifedipine; Photoperiod; Potassium Chloride; Rats; Rats, Sprague-Dawley; Serotonin; Tritium | 2002 |
Effect of melatonin and nifedipine on some antioxidant enzymes and different energy fuels in the blood and brain of global ischemic rats.
Topics: 3-Hydroxybutyric Acid; Animals; Antioxidants; Blood; Brain; Calcium Channel Blockers; Disease Models, Animal; Energy Metabolism; Enzymes; Erythrocytes; Free Radical Scavengers; Glucose; Glutathione Reductase; Ischemic Attack, Transient; L-Lactate Dehydrogenase; Male; Melatonin; Nifedipine; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury; Superoxide Dismutase | 2002 |
Tryptophan hydroxylase is modulated by L-type calcium channels in the rat pineal gland.
Topics: 5-Hydroxytryptophan; Acetylserotonin O-Methyltransferase; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Arylalkylamine N-Acetyltransferase; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Chromatography, High Pressure Liquid; Cyclic CMP; Dose-Response Relationship, Drug; Electrochemistry; In Vitro Techniques; Isoproterenol; Melatonin; Nifedipine; Norepinephrine; Pineal Gland; Rats; Rats, Wistar; Serotonin; Tryptophan Hydroxylase | 2008 |
Neuroprotection by melatonin on astrocytoma cell death.
Topics: Antioxidants; Apoptosis; Astrocytoma; Benzoquinones; Biological Transport; Calcium; Calcium Channel Blockers; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Lipoxygenase Inhibitors; Melatonin; Neomycin; Neuroprotective Agents; Nifedipine; Protein Synthesis Inhibitors; Receptors, Melatonin; Tryptamines; Type C Phospholipases | 2009 |